Միացյալ Թագավորություն - անգլերեն - MHRA (Medicines & Healthcare Products Regulatory Agency)

baxter healthcare ltd - mesna - solution for injection - 100mg/1ml

Միացյալ Թագավորություն - անգլերեն - MHRA (Medicines & Healthcare Products Regulatory Agency)

aop orphan ltd - naltrexone hydrochloride - oral tablet - 50mg

Կանադա - անգլերեն - Health Canada

baxter corporation - mesna - solution - 100mg - mesna 100mg - protective agents

Կանադա - անգլերեն - Health Canada

baxter corporation - mesna - solution - 100mg - mesna 100mg - protective agents

Միացյալ Թագավորություն - անգլերեն - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - naltrexone hydrochloride - oral tablet - 50mg

Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - bupivacaine hydrochloride, quantity: 1.25 mg/ml (equivalent: bupivacaine hydrochloride monohydrate, qty 1.32 mg/ml); fentanyl citrate, quantity: 7.9 microgram/ml (equivalent: fentanyl, qty 5 microgram/ml) - injection, solution - excipient ingredients: sodium chloride; water for injections; hydrochloric acid; sodium hydroxide - marcain 0.125% with fentanyl is intended for post-operative or obstetric epidural analgesia.

Իսրայել - անգլերեն - Ministry of Health

rafa laboratories ltd - morphine sulfate - solution for injection - morphine sulfate 20 mg/ml - morphine - morphine - morphine injection 20 mg/ml is a systemic opioid analgesic indicated only for iv, epidural and intrathecal infusion in the treatment of intractable chronic pain. it was developed for use in continuous microinfusion devices and the dosage requirements of the individual patient. morphine injetion 20 mg/ml is primarily intended for patients who are opioid -tolerant. morphine sulfate administered epidurally or intrathecally provides pain relief for extended periods without attendant loss of motor, sensory or sympathetic function

Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

rb pharmaceuticals limited - buprenorphine hydrochloride - solution for injection - 300 microgram(s)/millilitre - oripavine derivatives; buprenorphine

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

alkermes, inc. - naltrexone (unii: 5s6w795cqm) (naltrexone - unii:5s6w795cqm) - naltrexone 380 mg in 4 ml - treatment with vivitrol should be part of a comprehensive management program that includes psychosocial support. vivitrol is indicated for the treatment of alcohol dependence in patients who are able to abstain from alcohol in an outpatient setting prior to initiation of treatment with vivitrol. patients should not be actively drinking at the time of initial vivitrol administration. vivitrol is indicated for the prevention of relapse to opioid dependence, following opioid detoxification. vivitrol is contraindicated in: - patients receiving opioid analgesics [see warnings and precautions (5.3)] . - patients with current physiologic opioid dependence [see warnings and precautions (5.3)] . - patients in acute opioid withdrawal [see warnings and precautions (5.3)] . - any individual who has failed the naloxone challenge test or has a positive urine screen for opioids [see warnings and precautions (5.3)] . - patients who have previously exhibited hypersensitivity to naltrexone, plg, carboxymethylcellulose, or any

Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

indivior europe limited - buprenorphine hydrochloride - solution for injection - 300 microgram(s)/millilitre - oripavine derivatives; buprenorphine